GUIDE WIRE EXCHANGE CATHETER SYSTEM
    1.
    发明申请
    GUIDE WIRE EXCHANGE CATHETER SYSTEM 审中-公开
    指导式交流电源系统

    公开(公告)号:WO2008008428A1

    公开(公告)日:2008-01-17

    申请号:PCT/US2007/015885

    申请日:2007-07-11

    Abstract: A guide wire exchange system including an elongate, flexible, guide wire exchange catheter capable exchanging one guide wire for another in a safe, efficient, and secured manner, where a primary guide wire, after having been advanced through the body, is to be replaced with a secondary guide wire that is to be securely advanced through the body to the target site by the advancement of the exchange catheter over the path of the primary wire. The exchange catheter may include a securement element in order to releasably secure at least one guide wire to the exchange catheter at or near the distal end of the exchange catheter. Once secured, both the exchange catheter and the secured guide wire(s) may be advanced or retracted in a synchronous manner, without the possibility of divergence at the distal ends of the secured components as they are being manipulated by an operator.

    Abstract translation: 引导线交换系统,其包括细长的,柔性的导丝线交换导管,其能够以安全,有效和固定的方式交换一根导丝,其中主导丝在被推进穿过身体之后被更换 其中次级导丝将通过在主线路的路径上的交换导管的前进而被牢固地推进到身体到达目标位置。 交换导管可以包括固定元件,以便在交换导管的远端处或附近将至少一根导丝可释放地固定到交换导管。 一旦固定,交换导管和固定引导线可以以同步的方式前进或缩回,而不会在被操作者操纵的情况下在固定部件的远端发散。

    CENTRIFUGE
    2.
    发明申请
    CENTRIFUGE 审中-公开
    离心机

    公开(公告)号:WO2013123216A1

    公开(公告)日:2013-08-22

    申请号:PCT/US2013/026175

    申请日:2013-02-14

    Abstract: Centrifuges are useful to, among other things, remove red blood cells from whole blood and retain platelets and other factors in a reduced volume of plasma. Platelet rich plasma (PRP) and or platelet poor plasma (PPP) can be obtained rapidly and is ready for immediate injection into the host. Embodiments may include valves, operated manually or automatically, to open ports that discharge the excess red blood cells and the excess plasma into separate receivers while retaining the platelets and other factors in the centrifuge chamber. High speeds used allow simple and small embodiments to be used at the patients side during surgical procedures. The embodiments can also be used for the separation of liquids or slurries in other fields such as, for example, the separation of pigments or lubricants.

    Abstract translation: 除其他外,离心机可用于从全血中除去红细胞,并且在血浆体积减少中保留血小板和其他因子。 血小板富集血浆(PRP)和或血小板不足血浆(PPP)可以快速获得并准备立即注射入宿主。 实施例可以包括手动或自动地操作以打开将多余的红细胞和过量血浆排放到分离的接收器中的端口的阀,同时将血小板和其它因素保持在离心机室中。 使用的高速度允许在外科手术期间在患者侧使用简单和小的实施例。 这些实施方案也可用于在其它领域中分离液体或浆液,例如颜料或润滑剂的分离。

    HEMOSTATIC VESSEL PUNCTURE CLOSURE SYSTEM AND METHOD OF USE
    3.
    发明申请
    HEMOSTATIC VESSEL PUNCTURE CLOSURE SYSTEM AND METHOD OF USE 审中-公开
    HEMOSTATIC VESSEL PUNCTURE封闭系统及其使用方法

    公开(公告)号:WO1994017738A2

    公开(公告)日:1994-08-18

    申请号:PCT/US1994001337

    申请日:1994-02-02

    Abstract: A system, a closure (22), and method for sealing a percutaneous puncture (24) in a blood vessel (26). The puncture includes a tract (24A) leading to it from the skin of the being. The system includes an introducer sheath (28), a positioning device (200), a hemostatic puncture closure (22), and a deployment instrument (20). The positioning device positions the introducer sheath (28) at a desired position within the vessel (26). The deployment instrument includes a tubular carrier (100) having a distal end (102) storing the closure. The carrier is extended via an introducer sheath (28) through the tract (24A) and puncture (24) into the blood vessel (26). The closure comprises a rigid anchor (32), a spacer member (36), a compressed collagen plug (30), and a thin filament (34) connecting them in a pulley-like arrangement. The anchor has a centrally located domed projection (54). The carrier (100) ejects the anchor through the introducer (28) and puncture (24) and then draws it against the free end (28C) of the introducer (28). The instrument (100) and introducer (28) are then withdrawn together to pull the anchor (32) against the tissue contiguous with the puncture (24) inside the artery (26) and so that the domed portion (54) of the anchor (32) extends through the puncture (24). Further withdrawal draws the plug (30) and spacer (36) out of the carrier (100) into the puncture tract (24A), whereupon the spacer (36) engages the domed portion (54) of the anchor (32) to prevent the plug (30) from entering the puncture (24). A tensioning device (136) limits the force applied to the filament (34). The carrier also includes a tamper (130) which is used to mechanically deform the plug (30) within the tract (24A). Hemostasis occurs rapidly and the plug seals the tract.

    Abstract translation: 一种系统,封闭件(22)以及用于密封血管(26)中的经皮穿刺(24)的方法。 穿刺包括从皮肤的皮肤导致的道(24A)。 该系统包括导引鞘(28),定位装置(200),止血穿刺封闭物(22)和展开器具(20)。 定位装置将引导器护套(28)定位在容器(26)内的期望位置。 展开仪器包括具有存储封闭件的远端(102)的管状载体(100)。 载体通过引导器护套(28)延伸通过管道(24A)和穿刺(24)延伸到血管(26)中。 封闭件包括刚性锚固件(32),间隔件(36),压缩胶原塞(30)以及以滑轮状布置连接它们的细丝(34)。 锚固体具有中心定位的拱形凸起(54)。 托架(100)通过导引器(28)弹出锚固件并穿刺(24),然后将其拉到引导器(28)的自由端(28C)上。 然后将器械(100)和导引器(28)一起拉出以将锚固件(32)拉靠在与动脉(26)内部的穿刺(24)邻接的组织上,并且使锚固件的圆顶部分(54) 32)延伸穿过穿刺(24)。 进一步撤出将塞子(30)和间隔件(36)从载体(100)中抽出到穿刺管道(24A)中,于是间隔件(36)接合锚固件(32)的圆顶部分(54),以防止 插塞(30)进入穿刺(24)。 张紧装置(136)限制施加到细丝(34)的力。 载体还包括用于使管道(24A)内的塞子(30)机械地变形的篡改装置(130)。 止血发生迅速,塞子密封管道。

    RESORBABLE STRUCTURE FOR TREATING AND HEALING OF TISSUE DEFECTS
    5.
    发明申请
    RESORBABLE STRUCTURE FOR TREATING AND HEALING OF TISSUE DEFECTS 审中-公开
    组织缺陷治疗和治疗的可持续结构

    公开(公告)号:WO2004006973A1

    公开(公告)日:2004-01-22

    申请号:PCT/US2003/021054

    申请日:2003-07-03

    CPC classification number: A61L31/148 A61L27/56 A61L27/58 A61L31/146

    Abstract: Devices and processes (e.g., improved Plasticized Melt Flow processes (PMF) or improved Phase Separation Polymer Concentration (PSPC), etc.) used to make resorbable and non-resorbable structures for treating and/or healing of tissue defects are disclosed. Among the advantages of using these improved processes are the preservation of molecular weight and the broadening of the processing conditions for temperature sensitive polymers and therapies (e.g. polylactide, polyglycolide, polycaprolactone or Cisplatin, etc.). This reduction in processing temperature, pressure and time can help to preserve the molecular weight and/or integrity of the final product or any additive incorporated therein. Additionally, pore size and shape tailoring can increase the osteoconductive nature of the device.

    Abstract translation: 公开了用于制备用于治疗和/或愈合组织缺陷的可再吸收和不可再吸收的结构的装置和方法(例如,改进的增塑熔体流动方法(PMF)或改进的相分离聚合物浓度(PSPC)等)。 使用这些改进方法的优点在于保持分子量和加热温度敏感聚合物和疗法(例如聚丙交酯,聚乙交酯,聚己内酯或顺铂等)的加工条件。 加工温度,压力和时间的这种降低有助于保持最终产品或其中所含任何添加剂的分子量和/或完整性。 此外,孔径和形状调整可以增加器件的骨传导性质。

Patent Agency Ranking